Your session is about to expire
← Back to Search
Behavioural Intervention
A Study to Evaluate the Safety and Tolerability of Virtual Reality to Treat Gastroparesis
N/A
Waitlist Available
Led By Brian Lacy, MD
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 4 weeks
Summary
This trial is testing if virtual reality therapy is safe and effective for people with gastroparesis. Patients will use VR goggles to experience a virtual world, which might help reduce their nausea by distracting them from their symptoms.
Eligible Conditions
- Delayed Gastric Emptying
- Gastroparesis
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 4 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~4 weeks
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Patient-reported adverse events
Secondary study objectives
Change in Quality of life
Change in work productivity
Changes in abdominal pain
+4 moreTrial Design
2Treatment groups
Experimental Treatment
Placebo Group
Group I: Active VR GroupExperimental Treatment1 Intervention
Subjects will be provided an Oculus Go VR headset pre-loaded with a "menu" of virtual reality programs which have been designed specifically to treat both acute and chronic pain. Subjects are required to use the VR headset at home four times daily, prior to breakfast, lunch, dinner, and bedtime. Each session will last approximately 15 minutes.
Group II: Sham VR GroupPlacebo Group1 Intervention
Subjects will be provided an Oculus Go VR headset pre-loaded two-dimensional nature video. Subjects are required to use the VR headset at home four times daily, prior to breakfast, lunch, dinner, and bedtime. Each session will last approximately 15 minutes.
Find a Location
Who is running the clinical trial?
Mayo ClinicLead Sponsor
3,362 Previous Clinical Trials
3,065,931 Total Patients Enrolled
Brian Lacy, MDPrincipal InvestigatorMayo Clinic
1 Previous Clinical Trials
49 Total Patients Enrolled